347 related articles for article (PubMed ID: 15078474)
1. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
Odeh M; Sabo E; Srugo I; Oliven A
Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
4. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?
Goral V; Atayan Y; Kaplan A
Hepatogastroenterology; 2011; 58(107-108):943-8. PubMed ID: 21830421
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis.
Shiraki M; Terakura Y; Iwasa J; Shimizu M; Miwa Y; Murakami N; Nagaki M; Moriwaki H
Nutrition; 2010 Mar; 26(3):269-75. PubMed ID: 19695831
[TBL] [Abstract][Full Text] [Related]
7. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
8. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
9. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.
Kundra A; Jain A; Banga A; Bajaj G; Kar P
Clin Biochem; 2005 Aug; 38(8):696-9. PubMed ID: 15963970
[TBL] [Abstract][Full Text] [Related]
11. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Zhang W; Yue B; Wang GQ; Lu SL
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
[TBL] [Abstract][Full Text] [Related]
12. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.
Wasmuth HE; Kunz D; Yagmur E; Timmer-Stranghöner A; Vidacek D; Siewert E; Bach J; Geier A; Purucker EA; Gressner AM; Matern S; Lammert F
J Hepatol; 2005 Feb; 42(2):195-201. PubMed ID: 15664244
[TBL] [Abstract][Full Text] [Related]
13. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
15. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
[TBL] [Abstract][Full Text] [Related]
16. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin 1 and tumor necrosis factor alpha correlate with peritoneal adhesion grades in humans after major abdominal surgery.
Saba AA; Godziachvili V; Mavani AK; Silva YJ
Am Surg; 1998 Aug; 64(8):734-6; discussion 737. PubMed ID: 9697902
[TBL] [Abstract][Full Text] [Related]
18. Serum tumor necrosis factor (TNF) in the pathogenesis of clinical hepatic failure of HCV and/or HBV infection.
Zhang DF; Ren H; Jia XP; Zhou YS
Chin Med J (Engl); 1993 May; 106(5):335-8. PubMed ID: 8404274
[TBL] [Abstract][Full Text] [Related]
19. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
20. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
